Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients
- 1 March 1994
- journal article
- Published by Elsevier in Kidney International
- Vol. 45 (3) , 845-851
- https://doi.org/10.1038/ki.1994.111
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effects of oxygen breathing and erythropoietin on hypoxic vasodilation in uremic anemiaKidney International, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Correction of Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: Safety and Efficacy of One Year's Treatment in a European Multicentre Study of 150 Haemodialysis-Dependent Patients*Nephrology Dialysis Transplantation, 1989
- Erythropoietin-Associated Hypertension: What Role for Blood Viscosity Changes?Nephron, 1989
- USA Multicenter Clinical Trial with Recombinant Human Erythropoietin (Amgen)Published by S. Karger AG ,1988
- Peripheral Hemodynamics, Blood Viscosity, and the Renin-Angiotensin System in Hemodialysis Patients under Therapy with Recombinant Human ErythropoietinPublished by S. Karger AG ,1988
- Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in JapanThe International Journal of Artificial Organs, 1988
- HYPERTENSION, BLOOD VISCOSITY, AND CARDIOVASCULAR MORBIDITY IN RENAL FAILURE: IMPLICATIONS OF ERYTHROPOIETIN THERAPYThe Lancet, 1988
- Blood Pressure Changes during Treatment with Recombinant Human ErythropoietinPublished by S. Karger AG ,1987